Clinical Trial Update: Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating carvedilol CR (Coreg CR) and lisinopril on cardiovascular functional and structural markers in prehypertension. The study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prehypertension

Drugs mentioned

• COREG CR (carvedilol phosphate)
• Lisinopril (Lisinopril)

Snippet

Sponsor: University of Minnesota | Conditions: Pre-hypertension | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-12-17